Navigation Links
Study suggests symptom driven therapy for adults with asthma

For adults with the problem of asthma, it may help if they take corticosteroid medication when required, and not //take anti-inflammatory medication regularly.

People who took corticosteroids whenever they had the symptoms of an attack had the same rate of severe attacks and asthma related decline in lung function as those who were treated with the standard treatment of daily long-term control medication.

Asthma is considered mild when the symptoms exist as wheezing, coughing, or chest tightness more than twice a week and less than daily. Individuals suffering from mild asthmatic attacks do not have a disturbed night because of the symptoms more than two nights in a month.

A new research, which had cited these findings, also say that this treatment of corticosteroids been given symptomatically may not be a viable solution for people who have developed asthma recently, or those who are suffering from much more severe asthmatic periods. Hence this treatment method is only restricted to adults having chronic mild asthma. Current treatment for asthma suggests daily controlling medication, and for whom that may be cumbersome, the new method may be more suitable.
'"/>




Page: 1

Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... A stressful work environment ... can also decrease overall productivity and performance in the workplace. The goal of Clearview ... the last few weeks of April, Clearview Resolution Services will be shutting down the ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report from the ... for the 2015-16 school year across Wisconsin’s public schools, charter schools, and private ... patterns in student test score performance, the report’s limited analyses fail to provide ...
(Date:4/25/2017)... ... 2017 , ... Lake Park Dental is now accepting new patients with crooked ... FL. With the help of this highly-effective, yet convenient system, patients can straighten their ... and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear and Elizabeth ...
(Date:4/25/2017)... ... 2017 , ... As pharmaceutical companies are held to increasingly ... innovation in drug formulation and manufacturing. CoreRx offers its clients more than ... support of their development and manufacturing goals. , The company was created ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... 2017 Research and Markets has announced the ... to their offering. ... arthroscopy devices market to grow at a CAGR of 6.35% during ... Market 2017-2021, has been prepared based on an in-depth market analysis ... and its growth prospects over the coming years. The report also ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, and ... today announced the signing of a three-year exclusive ... will deploy a dedicated sales team to introduce ... U.S., primarily focused in 13 states in the ...
(Date:4/18/2017)... Research and Markets has announced the ... Imaging Equipment and Radiopharmaceuticals Market, Forecast to 2023" report ... ... as well as growth in the number of unit shipments ... market participants that design and manufacture molecular imaging equipment. ...
Breaking Medicine Technology: